Carlyle Group's $3.8B Bid For NBTY Could Face Competition
This article was originally published in The Tan Sheet
Executive Summary
The Carlyle Group's planned acquisition of NBTY for $3.8 billion may not be the only private equity offer to surface for the dietary supplement giant
You may also be interested in...
DSM's $1.1B Martek Acquisition Comes With Potential IP Expirations
Dutch ingredients giant Royal DSM N.V. incurs no incremental risk in acquiring Martek Biosciences despite the looming expiration dates for Martek's intellectual property, according to a market analyst.
NBTY Appoints GE Vet To Succeed CEO Rudolph
Newly private NBTY replaces long-time CEO Scott Rudolph with Jeffrey Nagel, a company outsider and supplement industry newcomer.
NBTY Appoints GE Vet To Succeed CEO Rudolph
The Carlyle Group, which closed its $4 billion leveraged buyout of NBTY October 1, brought nutritionals neophyte Nagel in to "support and enhance the management team," said NBTY President and Chief Financial Officer Kamil.